Reviva Pharmaceuticals Holdings Stock Alpha and Beta Analysis
| RVPH Stock | USD 1.11 0.07 6.73% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Reviva Pharmaceuticals Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Reviva Pharmaceuticals over a specified time horizon. Remember, high Reviva Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Reviva Pharmaceuticals' market risk premium analysis include:
Beta 3.57 | Alpha 0.47 | Risk 8.18 | Sharpe Ratio (0.10) | Expected Return (0.84) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Reviva |
Reviva Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Reviva Pharmaceuticals market risk premium is the additional return an investor will receive from holding Reviva Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Reviva Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Reviva Pharmaceuticals' performance over market.| α | 0.47 | β | 3.57 |
Reviva Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Reviva Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Reviva Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Reviva Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By understating and applying Reviva Pharmaceuticals stock market price indicators, traders can identify Reviva Pharmaceuticals position entry and exit signals to maximize returns.
Reviva Pharmaceuticals Return and Market Media
The median price of Reviva Pharmaceuticals for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 1.81 with a coefficient of variation of 21.28. The daily time series for the period is distributed with a sample standard deviation of 0.37, arithmetic mean of 1.76, and mean deviation of 0.28. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension ... | 12/16/2024 |
2 | Reviva Announces Pricing of 18.0 Million Public Offering of Common Stock and Warrants | 12/17/2024 |
3 | Reviva Pharmaceuticals Sees Unusually Large Options Volume - MarketBeat | 01/02/2025 |
4 | Reviva to Participate in the 2025 BIO CEO Investor Conference | 01/30/2025 |
5 | Acquisition by Vedanta Partners, Llc of 869565 shares of Reviva Pharmaceuticals at 2.4 subject to Rule 16b-3 | 02/07/2025 |
6 | Acquisition by Laxminarayan Bhat of 181500 shares of Reviva Pharmaceuticals at 1.8 subject to Rule 16b-3 | 02/13/2025 |
7 | Reviva Pharmaceuticals adjusts executive pay, grants stock options By Investing.com - Investing.com Nigeria | 02/18/2025 |
8 | Insider Trading | 03/04/2025 |
9 | Reviva Pharmaceuticals Holdings, Inc. Receives 11.40 Average Price Target from Analysts | 03/07/2025 |
About Reviva Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Reviva or other stocks. Alpha measures the amount that position in Reviva Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Reviva Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Reviva Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Reviva Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Reviva Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Reviva Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Reviva Pharmaceuticals' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Reviva Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Reviva Pharmaceuticals Backtesting, Reviva Pharmaceuticals Valuation, Reviva Pharmaceuticals Correlation, Reviva Pharmaceuticals Hype Analysis, Reviva Pharmaceuticals Volatility, Reviva Pharmaceuticals History and analyze Reviva Pharmaceuticals Performance. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Reviva Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.